moxifloxacin has been researched along with indacaterol in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (indacaterol) | Trials (indacaterol) | Recent Studies (post-2010) (indacaterol) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 309 | 101 | 250 |
| Protein | Taxonomy | moxifloxacin (IC50) | indacaterol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.3162 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0079 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drollmann, AF; Harris, S; Jennings, S; Khindri, S; Sabo, R; Woessner, R | 1 |
1 trial(s) available for moxifloxacin and indacaterol
| Article | Year |
|---|---|
Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Aza Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart; Humans; Indans; Male; Middle Aged; Moxifloxacin; Quinolines; Quinolones; Young Adult | 2011 |